Intraperitoneally injected matrine (50 mg/kg for 5 or 11 days from the onset of cachexia) in C26-bearing mice lowered serum levels of TNFα and IL-6 and preserved body and gastrocnemius muscle weights [226], downregulating the expression of atrogenes in skeletal muscle [227]. The gene discussed is TNF; the disease is Cachexia.